Cosentyx is a medication used to treat psoriasis and psoriatic arthritis. According to the manufacturer's website, the recommended starting dose for Cosentyx is 300 mg given as two subcutaneous injections of 150 mg each. After the initial dose, the recommended maintenance dose is 150 mg given as a subcutaneous injection every four weeks [2].

The dosage of Cosentyx should not be increased without consulting a healthcare provider. The frequency of dosage increase depends on the individual patient's response to the medication and the severity of their condition. According to Healthline, some patients may require a higher dose or more frequent dosing than the recommended maintenance dose [3].

Drugpatentwatch provides information on the patent status of Cosentyx, but does not provide information on dosage recommendations [1].

In summary, the recommended starting dose for Cosentyx is 300 mg, followed by a maintenance dose of 150 mg every four weeks. The frequency of dosage increase should be determined by a healthcare provider based on the individual patient's response to the medication and the severity of their condition. Patients should not increase their dosage without consulting a healthcare provider.

Sources:
[1] https://www.drugpatentwatch.com/p/biologics/tradename/COSENTYX
[2] https://www.cosentyx.com/psoriatic-arthritis/faq
[3] https://www.healthline.com/health/drugs/cosentyx-dosage